Triple negative breast cancer (TNBC), which comprises approximately 15% of all breast carcinomas [1], is defined as breast carcinoma that does not express estrogen receptor (ER), progesterone receptor (PgR) or human epidermal growth factor receptor type 2 (HER2). Here, ESR1 is linked to triple-negative breast carcinoma.